HYDRUS ENERGY ENGINEERING LIMITED

Financial Health Score: A

Explanation: Hydrus Energy Engineering Limited exhibits the financial equivalent of peak physical conditioning. The company demonstrates robust muscle mass (asset growth), a strong and steady pulse (cash flow and liquidity), and excellent stamina (retained profitability). With net assets swelling by over £1 million in the last year alone and a highly comfortable liquidity position, this business is in excellent financial health and shows few signs of systemic distress.

Key Vital Signs

1. Pulse & Circulation (Cash & Liquidity) * Cash Position: £685,216 (up from £509,844 in 2023 and a low of £26,324 in 2017). The company's financial pulse is strong and accelerating. * Current Ratio: 2.71x (Current Assets of £2.65m / Current Liabilities of £975k). For every pound of short-term debt, the business has £2.71 in short-term assets. This indicates excellent circulatory health—no risk of financial asphyxiation in the near term. * Working Capital: £1,674,572. A very healthy buffer to fund day-to-day operations without external support.

2. Blood Pressure (Leverage & Debt) * Total Liabilities vs. Net Assets: Total liabilities stand at £2.01m (including long-term debt and deferred tax) against Net Assets of £3.32m. The business is operating with low financial blood pressure; debt is well-managed and comfortably secured against the asset base. * Long-term Debt: £890,649. While this has increased from £530k, it is directly linked to significant capital investment (property and plant additions of £881k). This is healthy debt—akin to a mortgage on a growing asset, rather than reckless credit card spending.

3. Muscle Mass & Growth (Assets & Profitability) * Asset Growth: Total assets grew from £4.4m to £5.3m year-on-year. The company is actively building "muscle", with tangible fixed assets increasing by nearly £700k to £2.67m. * Profit Retention: The Profit and Loss reserve grew from £2.17m to £3.24m—a retained profit injection of approximately £1.07m. The business is generating healthy organic energy and keeping it in the system rather than bleeding it out.

4. Immune System Resilience (Historical Trend) * Over the last 7 years, net assets have grown consistently from £806k to £3.32m. The business has clearly recovered from any past vulnerabilities (such as the low cash position in 2017) and has built a very strong immune system against economic shocks.

Diagnosis

The patient is in exceptionally robust health. Hydrus Energy Engineering Limited is suffering from no acute financial illnesses. The business has transitioned from a leaner operation in 2017/2018 to a highly capitalized, asset-rich enterprise.

The most notable symptom in the latest period is significant capital investment. The business has expanded its property, plant, and machinery heavily, funded by a mix of retained profits and increased long-term bank financing. This indicates a company that is investing confidently in its future operational capacity.

There is one mild anomaly to monitor: Intercompany balances. Amounts owed by group undertakings jumped from £212,357 to £793,637. While this is easily affordable for a company with this balance sheet, it represents a financial "blood clot" where capital is tied up in the wider corporate group rather than being immediately accessible or invested in the core business.

Recommendations

Even a perfectly healthy patient needs a wellness plan to maintain their condition. I recommend the following:

1. Cardiovascular Exercise (Keep Cash Moving): With £685k in the bank and strong retained profits, the business has surplus financial energy. Ensure this cash is actively working for the business—whether through high-interest deposit accounts, paying down secured debt early to save on interest, or strategic reinvestment—rather than sitting idle.
2. Monitor the "Cholesterol" (Intercompany Debt): The near-fourfold increase in amounts owed by group undertakings (£793k) should be closely watched. Ensure these funds are collected on commercial terms and within a reasonable timeframe to prevent this capital from hardening the arteries of the core business.
3. Evaluate the ROI on New "Muscle" (Fixed Assets): The heavy capital expenditure (£881k) on property and plant must now be put to work. Management should closely track the return on these specific assets to ensure they generate the incremental revenue and margin required to service the associated long-term debt.
4. Maintain the Preventative Care Regime: The reduction in current trade creditors (from £778k down to £571k) suggests the business is paying suppliers faster, which is great for supply chain relationships. Continue to balance this with maximizing creditor terms where possible to optimize working capital.